These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 141627)

  • 21. Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease.
    Nagel JS; Johnson KA; Ichise M; English RJ; Walshe TM; Morris JH; Holman BL
    Clin Nucl Med; 1988 Jul; 13(7):486-90. PubMed ID: 2971497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Huntington's disease: the relationship between clinical signs, CAG repeats and the atrophy of the caudate nucleus in CT scans.
    Roth J; Zidovská J; Růzicková S; Havrdová E; Preiss M; Uhrová T; Línek V; Doubek P; Volfová M; Jech R; Bauer J; Růzicka E
    Sb Lek; 1999; 100(1):39-44. PubMed ID: 10860124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease.
    Harris GJ; Aylward EH; Peyser CE; Pearlson GD; Brandt J; Roberts-Twillie JV; Barta PE; Folstein SE
    Arch Neurol; 1996 Apr; 53(4):316-24. PubMed ID: 8929153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel DS; Berent S; Giordani B; Ehrenkaufer R; Jewett D; Hichwa R
    Ann Neurol; 1986 Sep; 20(3):296-303. PubMed ID: 2945510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy.
    Barr AN; Heinze WJ; Dobben GD; Valvassori GE; Sugar O
    Neurology; 1978 Nov; 28(11):1196-1200. PubMed ID: 152416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between CT scan changes and the duration of illness in Huntington's chorea (author's transl)].
    Konagaya M; Mukai E; Murakami N; Muroga T; Sobue I
    Rinsho Shinkeigaku; 1980 Feb; 20(2):113-20. PubMed ID: 6445252
    [No Abstract]   [Full Text] [Related]  

  • 29. Juvenile Huntington's disease.
    Srivastava T; Lal V; Prabhakar S
    Neurol India; 1999 Dec; 47(4):340-1. PubMed ID: 10625918
    [No Abstract]   [Full Text] [Related]  

  • 30. CT scan and neuropsychological correlates of Alzheimer's disease and Huntington's disease.
    Veroff AE; Pearlson GD; Ahn HS
    Brain Cogn; 1982 Apr; 1(2):177-84. PubMed ID: 6242676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients].
    Botsch H; Oepen G; Deuschl G; Wolff G
    Rofo; 1987 Dec; 147(6):666-8. PubMed ID: 2827263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single photon emission computed tomography in subjects at risk for Huntington's chorea.
    Leblhuber F; Brucker B; Reisecker F; Steinparz F; Windhager E; Trenkler J; Deisenhammer E
    J Neurol; 1990 Dec; 237(8):496-8. PubMed ID: 2150077
    [No Abstract]   [Full Text] [Related]  

  • 33. Prefrontal cortical blood flow and cognitive function in Huntington's disease.
    Weinberger DR; Berman KF; Iadarola M; Driesen N; Zec RF
    J Neurol Neurosurg Psychiatry; 1988 Jan; 51(1):94-104. PubMed ID: 2965218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomographic, neurologic, and neuropsychological correlates of Huntington's disease.
    Sax DS; O'Donnell B; Butters N; Menzer L; Montgomery K; Kayne HL
    Int J Neurosci; 1983; 18(1-2):21-36. PubMed ID: 6220990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
    Peña-Sánchez M; Riverón-Forment G; Zaldívar-Vaillant T; Soto-Lavastida A; Borrero-Sánchez J; Lara-Fernández G; Esteban-Hernández EM; Hernández-Díaz Z; González-Quevedo A; Fernández-Almirall I; Pérez-López C; Castillo-Casañas Y; Martínez-Bonne O; Cabrera-Rivero A; Valdés-Ramos L; Guerra-Badía R; Fernández-Carriera R; Menéndez-Sainz MC; González-García S
    Clin Biochem; 2015 Dec; 48(18):1258-63. PubMed ID: 26210848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
    Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
    Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computed tomography in the diagnosis of Huntington's disease.
    Lee CC; Chen ST; Lu CS; Hsi MS
    Changgeng Yi Xue Za Zhi; 1986 Sep; 9(3):157-64. PubMed ID: 2970288
    [No Abstract]   [Full Text] [Related]  

  • 38. A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain.
    Curtis MA; Waldvogel HJ; Synek B; Faull RL
    J Chem Neuroanat; 2005 Jul; 30(1):55-66. PubMed ID: 16108100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain morphology and sleep EEG in patients with Huntington's disease.
    Wiegand M; Möller AA; Schreiber W; Lauer C; Krieg JC
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(3):148-52. PubMed ID: 1827599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thirteen years longitudinal study of computed tomography, visual electrophysiology and neuropsychological changes in Huntington's chorea patients and 50% at-risk asymptomatic subjects.
    Cala LA; Black JL; Collins DW; Ellison RM; Zubrick SA
    Clin Exp Neurol; 1990; 27():43-63. PubMed ID: 2151811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.